Quantification by LC-MS(E) of outer membrane vesicle proteins of the Bexsero® vaccine (Q42231387)

19 October 2017

Quantification by LC-MS(E) of outer membrane vesicle proteins of the Bexsero® vaccine (English)

1 reference

19 October 2017

9

1 reference

19 October 2017

Chiara Tani

1

1 reference

19 October 2017

Maria Stella

2

1 reference

19 October 2017

Danilo Donnarumma

3

1 reference

19 October 2017

Massimiliano Biagini

4

1 reference

19 October 2017

Pierino Parente

5

1 reference

19 October 2017

Alessandro Vadi

6

1 reference

19 October 2017

Claudia Magagnoli

7

1 reference

19 October 2017

Paolo Costantino

8

1 reference

19 October 2017

Nathalie Norais

10

1 reference

19 October 2017

language of work or name

English

0 references

publication date

23 January 2014

1 reference

19 October 2017

1 reference

19 October 2017

32

1 reference

19 October 2017

11

1 reference

19 October 2017

1273-1279

1 reference

Global epidemiology of meningococcal disease.

19 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Immunologic response of man to group B meningococcal polysaccharide vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Reverse vaccinology, a genome-based approach to vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Bexsero: a multicomponent vaccine for prevention of meningococcal disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Positive phase 2 results for immatics colorectal cancer vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Characterization of meningococcal serogroup B outer membrane vesicle vaccines from strain 44/76 after growth in different media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Characterization of the protein content of a meningococcal outer membrane vesicle vaccine by polyacrylamide gel electrophoresis and mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Proteomic study via a non-gel based approach of meningococcal outer membrane vesicle vaccine obtained from strain CU385: a road map for discovering new antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98/254

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Analysis and quantification of diagnostic serum markers and protein signatures for Gaucher disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Simultaneous qualitative and quantitative analysis of the Escherichia coli proteome: a sweet tale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Structural organization of NadADelta(351-405), a recombinant MenB vaccine component, by its physico-chemical characterization at drug substance level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Structural characterisation, stability and antibody recognition of chimeric NHBA-GNA1030: an investigational vaccine component against Neisseria meningitidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC-MSE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Label-free mass spectrometry-based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Simultaneous quantification of hemagglutinin and neuraminidase of influenza virus using isotope dilution mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

DOLOP--database of bacterial lipoproteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Understanding the immune responses to the meningococcal strain-specific vaccine MeNZB measured in studies of infants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Lipoproteins of bacterial pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Association of Acinetobacter baumannii EF-Tu with cell surface, outer membrane vesicles, and fibronectin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Surfome analysis as a fast track to vaccine discovery: identification of a novel protective antigen for Group B Streptococcus hypervirulent strain COH1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Quantitative proteomics reveals distinct differences in the protein content of outer membrane vesicle vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Immunization with the recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Omp85 proteins of Neisseria gonorrhoeae and Neisseria meningitidis are similar to Haemophilus influenzae D-15-Ag and Pasteurella multocida Oma87.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Neisseria meningitidis antigen NMB0088: sequence variability, protein topology and vaccine potential.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

The Neisseria meningitidis macrophage infectivity potentiator protein induces cross-strain serum bactericidal activity and is a potential serogroup B vaccine candidate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

An outer membrane receptor of Neisseria meningitidis involved in zinc acquisition with vaccine potential.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Variable expression of class 1 outer membrane protein in Neisseria meningitidis is caused by variation in the spacing between the -10 and -35 regions of the promoter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Variable expression of the Opc outer membrane protein in Neisseria meningitidis is caused by size variation of a promoter containing poly-cytidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

Identification of proteins of Neisseria meningitidis induced under iron-limiting conditions using the isobaric tandem mass tag (TMT) labeling approach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

The zinc-responsive regulon of Neisseria meningitidis comprises 17 genes under control of a Zur element

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.011

10.1016/J.VACCINE.2014.01.011

7 January 2021

Identifiers

DOI

1 reference

19 October 2017

1 reference